NovaRad has recently received U.S. Food and Drug Administration (FDA)clearance for reading and interpreting mammography studies for its NovaPACS which is used for the distribution and viewing of mammography studies, including window,level,zoom and volumetric measurements.
If you enjoy this content, please share it with a colleague
Related Content
Decades since the advent of breast scanning technology, innovations in noninvasive diagnostic imaging provide new ...
May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...
May 1, 2024 — The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast ...
The Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition brought ...
April 30, 2024 — The U.S. Preventive Services Task Force (Task Force) today published a final recommendation statement ...
The rapid growth of healthcare data has reached unprecedented heights, making up about 30% of the world’s stored data.¹ ...
Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...
April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...
April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced ...
March 20, 2024 — Interval breast cancer is one that appears between two reviews of a screening program. That is, it is ...